Literature DB >> 6814637

Branhamella catarrhalis infection of the lower respiratory tract: reliable diagnosis by sputum examination.

P E Thornley, J Aitken, C J Drennan, J MacVicar, N J Slevin.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6814637      PMCID： PMC1500508          DOI： 10.1136/bmj.285.6354.1537

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  A COMPARISON OF TRANSTRACHEAL ASPIRATION WITH OTHER METHODS OF DETERMINING THE BACTERIAL FLORA OF THE LOWER RESPIRATORY TRACT.

Authors:  D V PECORA
Journal:  N Engl J Med       Date:  1963-09-26       Impact factor: 91.245

2.  Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host.

Authors:  D J McNeely; C S Kitchens; R M Kluge
Journal:  Am Rev Respir Dis       Date:  1976-08

3.  Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.

Authors:  G Ninane; J Joly; M Kraytman
Journal:  Br Med J       Date:  1978-02-04

4.  Branhamella (Neisseria) catarrhalis: criteria for laboratory identification.

Authors:  G V Doern; S A Morse
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948
  4 in total
  15 in total

1.  Interpretation of gram-stained sputa containing Moraxella (Branhamella) catarrhalis.

Authors:  S M Ainsworth; S B Nagy; L A Morgan; G R Miller; J L Perry
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

2.  Pneumonia due to Branhamella catarrhalis.

Authors:  S Capewell; D T McLeod; M J Croughan; F Ahmad; M A Calder; A Seaton
Journal:  Thorax       Date:  1988-11       Impact factor: 9.139

3.  Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.

Authors:  P E Thornley; J M Aitken; G M Nichol; N J Slevin
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response.

Authors:  D T McLeod; F Ahmad; M J Croughan; M A Calder
Journal:  Drugs       Date:  1986       Impact factor: 9.546

5.  Bronchopulmonary infection due to Branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; J T Power; M A Calder; A Seaton
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

6.  In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.

Authors:  K G Sweeney; A Verghese; C A Needham
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

7.  Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis.

Authors:  R J Wallace; L C Steele; D L Brooks; J I Luman; R W Wilson; J W McLarty
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

8.  Severe respiratory infection with Branhamella catarrhalis in an African child.

Authors:  J Bogaerts; P Lepage; J P Vande Weghe; J Vandepitte
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

9.  The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections.

Authors:  M A Calder; M J Croughan; D T McLeod; F Ahmad
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Sensitivity of Branhamella catarrhalis to oral antibiotics.

Authors:  I Kallings
Journal:  Drugs       Date:  1986       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.